Salmonellosis cost-effectiveness of therapy

Salmonellosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Salmonellosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Salmonellosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Salmonellosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Salmonellosis cost-effectiveness of therapy
CDC on Salmonellosis cost-effectiveness of therapy
Salmonellosis cost-effectiveness of therapy in the news
Blogs on Salmonellosis cost-effectiveness of therapy
Directions to Hospitals Treating Salmonellosis
Risk calculators and risk factors for Salmonellosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview

Although most cases of salmonellosis are not complicated, supportive and symptomatic treatment are mandatory in order to avoid worsening of the condition. Additionally, salmonellosis may incapacitate the affected persons for several days, jeopardizing their ability to work. Therefore, the treatment and prevention of salmonellosis may be considered cost-effective.

References

Template:WikiDoc Sources